These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31328852)

  • 1. Role of the cytosolic domain of occludin in trafficking and hepatitis C virus infection.
    Lavie M; Linna L; Moustafa RI; Belouzard S; Fukasawa M; Dubuisson J
    Traffic; 2019 Oct; 20(10):753-773. PubMed ID: 31328852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
    Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
    PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.
    Sendi H; Mehrab-Mohseni M; Foureau DM; Ghosh S; Walling TL; Steuerwald N; Zamor PJ; Kaplan KJ; Jacobs C; Ahrens WA; Russo MW; Clemens MG; Schrum LW; Bonkovsky HL
    Liver Int; 2015 Apr; 35(4):1315-23. PubMed ID: 25302477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
    Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.
    Sourisseau M; Michta ML; Zony C; Israelow B; Hopcraft SE; Narbus CM; Parra Martín A; Evans MJ
    PLoS Pathog; 2013 Mar; 9(3):e1003244. PubMed ID: 23555257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model.
    Shimizu Y; Shirasago Y; Kondoh M; Suzuki T; Wakita T; Hanada K; Yagi K; Fukasawa M
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occludin stalls HCV particle dynamics apart from hepatocyte tight junctions, promoting virion internalization.
    Deffieu MS; Clément CMH; Dorobantu CM; Partiot E; Bare Y; Faklaris O; Rivière B; Ayala-Nunez NV; Baumert TF; Rondé P; Mély Y; Lucansky V; Gaudin R
    Hepatology; 2022 Oct; 76(4):1164-1179. PubMed ID: 35388524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C Virus Disrupts Annexin 5-Mediated Occludin Integrity through Downregulation of Protein Kinase Cα (PKCα) and PKCη Expression, Thereby Promoting Viral Propagation.
    Abe T; Marutani Y; Deng L; Matsui C; Fukasawa M; Suzuki R; Wakita T; Matsuura Y; Shoji I
    J Virol; 2023 Jun; 97(6):e0065523. PubMed ID: 37272842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection.
    Shirasago Y; Shimizu Y; Tanida I; Suzuki T; Suzuki R; Sugiyama K; Wakita T; Hanada K; Yagi K; Kondoh M; Fukasawa M
    Biol Pharm Bull; 2016 May; 39(5):839-48. PubMed ID: 26887345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The second extracellular loop dictates Occludin-mediated HCV entry.
    Liu S; Kuo W; Yang W; Liu W; Gibson GA; Dorko K; Watkins SC; Strom SC; Wang T
    Virology; 2010 Nov; 407(1):160-70. PubMed ID: 20822789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species-specific regions of occludin required by hepatitis C virus for cell entry.
    Michta ML; Hopcraft SE; Narbus CM; Kratovac Z; Israelow B; Sourisseau M; Evans MJ
    J Virol; 2010 Nov; 84(22):11696-708. PubMed ID: 20844048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.
    Fénéant L; Ghosn J; Fouquet B; Helle F; Belouzard S; Vausselin T; Séron K; Delfraissy JF; Dubuisson J; Misrahi M; Cocquerel L
    PLoS One; 2015; 10(11):e0142539. PubMed ID: 26561856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection.
    Liu S; Yang W; Shen L; Turner JR; Coyne CB; Wang T
    J Virol; 2009 Feb; 83(4):2011-4. PubMed ID: 19052094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process.
    Baktash Y; Madhav A; Coller KE; Randall G
    Cell Host Microbe; 2018 Mar; 23(3):382-394.e5. PubMed ID: 29544098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum.
    Benedicto I; Molina-Jiménez F; Barreiro O; Maldonado-Rodríguez A; Prieto J; Moreno-Otero R; Aldabe R; López-Cabrera M; Majano PL
    Hepatology; 2008 Oct; 48(4):1044-53. PubMed ID: 18802961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.
    Li Q; Sodroski C; Lowey B; Schweitzer CJ; Cha H; Zhang F; Liang TJ
    Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7620-5. PubMed ID: 27298373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.
    Benedicto I; Molina-Jiménez F; Bartosch B; Cosset FL; Lavillette D; Prieto J; Moreno-Otero R; Valenzuela-Fernández A; Aldabe R; López-Cabrera M; Majano PL
    J Virol; 2009 Aug; 83(16):8012-20. PubMed ID: 19515778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry.
    Kohaar I; Ploss A; Korol E; Mu K; Schoggins JW; O'Brien TR; Rice CM; Prokunina-Olsson L
    J Virol; 2010 Jul; 84(14):6987-94. PubMed ID: 20463075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion expression of Occludin extracellular loops and an α-helical bundle: A new research model for tight junction.
    Chi X; Zhao X; Wang W; Niu Y; Cheng M; Liu X; Cui S; Yang W
    PLoS One; 2017; 12(4):e0175516. PubMed ID: 28448574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occludin-binding single-chain variable fragment and antigen-binding fragment antibodies prevent hepatitis C virus infection.
    Shimizu Y; Shinoda T; Shirasago Y; Kondoh M; Shinya N; Hanada K; Yagi K; Suzuki T; Wakita T; Kimura-Someya T; Shirouzu M; Fukasawa M
    FEBS Lett; 2021 Jan; 595(2):220-229. PubMed ID: 33113151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.